Leucemia Mielóide Crônica: transplante de medula óssea

Aranha, Francisco J. P.
Rev. bras. hematol. hemoter ; 30(supl.1): 41-46, abr. 2008. ilus
Artículo en Portugués | LILACS | ID: lil-496181

Documentos relacionados

  1. Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
  2. Measurable residual disease in chronic myeloid leukemia.
  3. The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.
  4. Chronic Myeloid Leukemia During Pregnancy with Placental Involvement: Case Report and Literature Review.
  5. Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
  6. Single amino acid-based PROTACs trigger degradation of the oncogenic kinase BCR-ABL in chronic myeloid leukemia (CML).
  7. Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
  8. Effect of Imatinib Mesylate on Growth in Pediatric Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis.
  9. Tyrosine Kinase Inhibitor Therapies in Chronic Myeloid Leukemia: Effects on Clinical Characteristics and Triglyceride-to-High Density Lipoprotein Cholesterol Ratio.
  10. Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.